En los últimos cuatro años, hemos visto que la inteligencia artificial (IA) es capaz de intervenir en todas las fases de la investigación científica, sin embargo, conlleva riesgos: hoy más de la mitad...

Integron insertion sites engineered into counterselection markers allow large-scale and high-throughput capture of integron-encoded genes from genetically tractable bacteria or DNA samples.

Antimicrobial resistance (AMR) is a critical global health challenge that is increasingly being addressed through quantitative and systems-level appro…

Los resultados, aparentemente positivos, de un ensayo clínico en fase 3 que persigue validar la seguridad y eficacia de una nueva terapia contra el melanoma han saltado a los titulares […]

The study shows that metabolic mutations in Pseudomonas aeruginosa lead to pyruvate secretion, which reduces oxidative stress, dampens immune responses, promoting bacterial survival and persistence in...

The study of bacterial antagonism, and specifically type VI secretion system (T6SS)-mediated antagonism, has gained momentum over the last decade in research laboratories across the world. The T6SS is...

In this work, authors show that the loss of the carbapenem porin OprD in Pseudomonas aeruginosa reduces mucus entrapment and enhances airway epithelial barrier crossing, illustrating how antibiotic re...

Antimicrobial resistance (AMR) threatens global health. A promising and underexplored strategy to tackle this problem is sequential therapies exploiting collateral sensitivity (CS), whereby resistance...

Sir David Attenborough has released an audio message on Thursday thanking the public for the goodwill messages sent in the run-up to his 100th birthday

Here, the authors describe negative hysteresis as a phenomenon where the initial exposure of Pseudomonas aeruginosa to β-lactam antibiotics causes cellular sensitization towards aminoglycoside antibio...

Una de las mayores paradojas de las enfermedades raras es que no son tan raras. Globalmente afectan a millones de personas, a pesar de que cada una afecta a pocos pacientes.

El microorganismo recién descubierto parece mostrar resistencia a una decena de modernos antibióticos, pero también inhibe el crecimiento de otras bacterias